SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001044321-14-000075
Filing Date
2014-05-08
Accepted
2014-05-08 13:59:15
Documents
1
Group Members
ADAM C. STETTNERAUSTIN W. MARXEAWM INVESTMENT COMPANY, INC.DAVID M. GREENHOUSELS ADVISERS, LLCMG ADVISERS, LLCSPECIAL SITUATIONS LIFE SCIENCES FUND, L.P.SPECIAL SITUATIONS PRIVATE EQUITY FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 ADAMIS 13G/A adamis13gt1.txt SC 13G/A 8519
  Complete submission text file 0001044321-14-000075.txt   10497
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Subject) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-45279 | Film No.: 14824211
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022
Business Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022 2123196670
MARXE AUSTIN W & GREENHOUSE DAVID M (Filed by) CIK: 0001044321 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A